| Kelly Van, RN | |
|
2615 Edwards St, Alton, IL 62002-3915 | |
| (618) 462-2331 | |
| (618) 462-2504 |
| Full Name | Kelly Van |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Addiction (substance Use Disorder) |
| Location | 2615 Edwards St, Alton, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740054378 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WA0400X | Registered Nurse - Addiction (substance Use Disorder) | 043.105278 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Van, RN 902 W Main St, West Frankfort, IL 62896-2210 Ph: (618) 937-6483 | Kelly Van, RN 2615 Edwards St, Alton, IL 62002-3915 Ph: (618) 462-2331 |
News Archive
An international research team led by the Institute of Bioengineering and Nanotechnology of the Agency for Science, Technology and Research and IBM Research developed a synthetic molecule that can kill five deadly types of multidrug-resistant bacteria with limited, if any, side effects.
Using sugar molecules researchers from the University of Copenhagen have developed a new vaccine for hay fever that may reduce treatment times and increase the effect of treatments.
Efforts to curb poverty worldwide have been slowed by the global economic situation, but the developing world is still on track to reach the Millennium Development Goal (MDG) of halving the number of people living on less than $1 per day by 2015 - according to an annual U.N. report (.pdf) on the MDGs, which this year shows a "mixed picture" on reaching all eight targets - the Associated Press reports (Lederer, 6/23).
Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.
Genetic mutations that promote the growth of the most common type of adult brain tumors can be accurately detected and monitored in blood samples using an enhanced form of liquid biopsy developed by researchers at Massachusetts General Hospital.
› Verified 8 days ago
Katherine Collins-whittaker, CNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 550 Landmarks Blvd, Alton, IL 62002 Phone: 618-463-5905 Fax: 618-463-5935 | |
Sharon Jameson, PMHNP-BC Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 4 Memorial Dr Ste 210, Alton, IL 62002 Phone: 618-465-8829 Fax: 618-465-5499 | |
Mary Wiseman, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 12 Lakeridge Trl, Alton, IL 62002 Phone: 618-593-2439 | |
Andrew James Standefer, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7311 | |
Mr. Steven A Nolan, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1407 Elmwood Dr, Alton, IL 62002 Phone: 618-466-8768 | |
Jennifer Lynn Singleton, APRN Registered Nurse Medicare: Medicare Enrolled Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Jerry D Kinney, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3620 Bloomer Dr, Alton, IL 62002 Phone: 618-465-2016 |